Understanding brain connectivity changes in Alzheimer's disease using advanced imaging and protein analysis

Incorporating Spatial Proteomics to Understand the Basis of Hyper and Hypoconnectivity in mouse models of AD

NIH-funded research Baylor College of Medicine · NIH-11116981

This study is looking at how Alzheimer's disease affects connections in the brain by using advanced imaging and protein analysis in mice, hoping to uncover how certain proteins might influence the disease's progression.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBaylor College of Medicine NIH-funded
Lab location1 site (Houston, United States)
Project IDNIH-11116981 on NIH RePORTER

What this research studies

This research investigates the changes in brain connectivity associated with Alzheimer's disease by combining high-resolution MRI imaging with spatial proteomics in mouse models. The study aims to identify how different proteins are expressed in areas of the brain that show either increased or decreased connectivity. By utilizing machine learning, researchers will analyze these data to better understand the underlying mechanisms of Alzheimer's disease. This approach could lead to insights into the roles of specific proteins in the progression of the disease.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with a diagnosis of Alzheimer's disease or those at risk for developing the condition.

Not a fit: Patients with other forms of dementia or cognitive impairment unrelated to Alzheimer's disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic targets for Alzheimer's disease, potentially improving treatment options for patients.

How similar studies have performed: Previous research has shown promise in using imaging and proteomic techniques to study Alzheimer's disease, suggesting that this approach could yield valuable insights.

Where this research is happening

Houston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndrome
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.